BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30708041)

  • 41. Non-invasive metabolic imaging of brain tumours in the era of precision medicine.
    Kim MM; Parolia A; Dunphy MP; Venneti S
    Nat Rev Clin Oncol; 2016 Dec; 13(12):725-739. PubMed ID: 27430748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Succinate Anaplerosis Has an Onco-Driving Potential in Prostate Cancer Cells.
    Sant'Anna-Silva ACB; Perez-Valencia JA; Sciacovelli M; Lalou C; Sarlak S; Tronci L; Nikitopoulou E; Meszaros AT; Frezza C; Rossignol R; Gnaiger E; Klocker H
    Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33917317
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Noncoding RNA for personalized prostate cancer treatment: utilizing the 'dark matters' of the genome.
    Hua J; Lu J; Isaev K; Soares F; Guo H; Ahmed M; He HH
    Per Med; 2017 Mar; 14(2):159-169. PubMed ID: 29754555
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of serine metabolism in lung cancer: From oncogenesis to tumor treatment.
    Zhou X; Tian C; Cao Y; Zhao M; Wang K
    Front Genet; 2022; 13():1084609. PubMed ID: 36699468
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell death of prostate cancer cells by specific amino acid restriction depends on alterations of glucose metabolism.
    Fu YM; Lin H; Liu X; Fang W; Meadows GG
    J Cell Physiol; 2010 Aug; 224(2):491-500. PubMed ID: 20432447
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative Method to Investigate the Balance between Metabolism and Proteome Biomass: Starting from Glycine.
    Gu H; Carroll PA; Du J; Zhu J; Neto FC; Eisenman RN; Raftery D
    Angew Chem Int Ed Engl; 2016 Dec; 55(50):15646-15650. PubMed ID: 27860107
    [TBL] [Abstract][Full Text] [Related]  

  • 47. THE IMPORTANCE OF GLYOXYLATE IN AMINO ACID BIOSYNTHESIS IN PLANTS.
    SINHA SK; COSSINS EA
    Biochem J; 1965 Jul; 96(1):254-61. PubMed ID: 14343140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advances in Biomarkers for PCa Diagnostics and Prognostics-A Way towards Personalized Medicine.
    Stephan C; Jung K
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29053613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protein turnover, ureagenesis and gluconeogenesis.
    Schutz Y
    Int J Vitam Nutr Res; 2011 Mar; 81(2-3):101-7. PubMed ID: 22139560
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting the 5'-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer.
    Popovics P; Frigo DE; Schally AV; Rick FG
    Expert Opin Ther Targets; 2015 May; 19(5):617-32. PubMed ID: 25600663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic Vulnerabilities of Prostate Cancer: Diagnostic and Therapeutic Opportunities.
    Zadra G; Loda M
    Cold Spring Harb Perspect Med; 2018 Oct; 8(10):. PubMed ID: 29229664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolic deregulation in prostate cancer.
    Srihari S; Kwong R; Tran K; Simpson R; Tattam P; Smith E
    Mol Omics; 2018 Oct; 14(5):320-329. PubMed ID: 30215656
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots.
    Costello LC; Franklin RB
    Mol Cancer; 2006 May; 5():17. PubMed ID: 16700911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Placental transport and metabolism of amino acids.
    Battaglia FC; Regnault TR
    Placenta; 2001; 22(2-3):145-61. PubMed ID: 11170819
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sarcosine influences apoptosis and growth of prostate cells via cell-type specific regulation of distinct sets of genes.
    Rodrigo MAM; Strmiska V; Horackova E; Buchtelova H; Michalek P; Stiborova M; Eckschlager T; Adam V; Heger Z
    Prostate; 2018 Feb; 78(2):104-112. PubMed ID: 29105933
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The free amino acid pool in Leishmania tropica promastigotes.
    Simon MW; Jayasimhulu K; Mukkada AJ
    Mol Biochem Parasitol; 1983 Sep; 9(1):47-57. PubMed ID: 6669160
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor necrosis factor alpha increases aerobic glycolysis and reduces oxidative metabolism in prostate epithelial cells.
    Vaughan RA; Garcia-Smith R; Trujillo KA; Bisoffi M
    Prostate; 2013 Oct; 73(14):1538-46. PubMed ID: 23818177
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular Imaging of Prostate Cancer.
    Wibmer AG; Burger IA; Sala E; Hricak H; Weber WA; Vargas HA
    Radiographics; 2016; 36(1):142-59. PubMed ID: 26587888
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Positive regulation of prostate cancer cell growth by lipid droplet forming and processing enzymes DGAT1 and ABHD5.
    Mitra R; Le TT; Gorjala P; Goodman OB
    BMC Cancer; 2017 Sep; 17(1):631. PubMed ID: 28877685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Personalized treatment of prostate cancer: better knowledge of the patient, the disease and the medicine.
    Aoun F; Rassy EE; Assi T; Kattan J
    Future Oncol; 2016 Oct; 12(20):2359-61. PubMed ID: 27424848
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.